VYGR R&D Expenses
Voyager Therapeutics Inc · R&D Expenses
VYGR R&D Expenses
Latest reported$118.46Mperiod ending
VYGR TTM R&D Expenses ($8.90M → $118.46M)
TTM R&D Expenses
High-resolution chart · PNG
VYGR r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 118,461,000 | |
| 127,750,000 | |
| 134,674,000 | |
| 134,305,000 | |
| 128,680,000 | |
| 131,802,000 | |
| 126,172,000 | |
| 115,010,000 | |
| 110,632,000 | |
| 98,165,000 | |
| 90,837,000 | |
| 80,967,000 | |
| 74,441,000 | |
| 64,983,000 | |
| 60,764,000 | |
| 60,233,000 | |
| 58,810,000 | |
| 65,788,000 | |
| 73,785,000 | |
| 81,761,000 | |
| 88,886,000 | |
| 98,804,000 | |
| 108,751,999 | |
| 123,306,999 | |
| 128,044,999 | |
| 127,197,999 | |
| 119,735,000 | |
| 100,098,000 | |
| 86,953,000 | |
| 74,884,000 | |
| 64,906,000 | |
| 61,319,000 | |
| 64,248,000 | |
| 63,041,000 | |
| 62,260,000 | |
| 61,656,000 | |
| 52,404,000 | |
| 47,588,000 | |
| 42,248,000 | |
| 38,745,000 | |
| 34,917,000 | |
| 30,888,000 | |
| 27,679,000 | |
| 21,419,000 | |
| 17,337,000 | |
| 12,989,000 | |
| 8,898,000 |